Johann de Bono, MD, MSc, PhD, FRCP, FMedSci's avatar
Johann de Bono, MD, MSc, PhD, FRCP, FMedSci
Director of the Drug Development Unit, and Head of the Prostate Cancer Targeted Therapy Group at The Institute of Cancer Research
  • Hematology and Oncology
  • Director of the Drug Development Unit, and Head of the Prostate Cancer Targeted Therapy Group at The Institute of Cancer Research
Want to learn more about Johann?

Join NEJM Resident 360!